{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:18:34Z","timestamp":1781770714505,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:00:00Z","timestamp":1669334400000},"content-version":"vor","delay-in-days":2704,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1111\/ajt.13191","type":"journal-article","created":{"date-parts":[[2015,2,23]],"date-time":"2015-02-23T13:21:43Z","timestamp":1424697703000},"page":"1923-1932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study"],"prefix":"10.1016","volume":"15","author":[{"given":"R.","family":"Hellemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berthoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Merville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ouali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Squifflet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Wissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Abramowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.13191_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0b013e3181a236e0","article-title":"Acute rejection and chronic nephropathy: A systematic review of the literature","volume":"87","author":"Wu","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13191_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13191_bib3","article-title":"Interleukin 2 receptor antagonists for kidney transplant recipients","volume":"1","author":"Webster","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/ajt.13191_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1681\/ASN.2008101037","article-title":"Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients","volume":"20","author":"No\u00ebl","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/ajt.13191_bib5","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa060068","article-title":"Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation","volume":"355","author":"Brennan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13191_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJM199004263221702","article-title":"Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts","volume":"322","author":"Soulillou","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13191_bib7","first-page":"817","article-title":"Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: Results of a randomized study","volume":"25","author":"Kriaa","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1111\/ajt.13191_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-6143.2002.020109.x","article-title":"Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy","volume":"2","author":"Lebranchu","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.13191_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.tp.0000268084.64888.f3","article-title":"Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: Efficacy and safety","volume":"84","author":"Kyll\u00f6nen","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13191_bib10","first-page":"713","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int 1999"},{"key":"10.1111\/ajt.13191_bib11","article-title":"ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2011","year":"2014","journal-title":"Academic Medical Center, Department of Medical Informatics, Amsterdam, The Netherlands, 2013"},{"key":"10.1111\/ajt.13191_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/TP.0b013e3182708ea8","article-title":"Kidney graft survival in Europe and the United States: Strikingly different long-term outcomes","volume":"95","author":"Gondos","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13191_bib13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.ajkd.2009.06.031","article-title":"Proteinuria in kidney transplant recipients: Prevalence, prognosis, and evidence-based management","volume":"54","author":"Knoll","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/ajt.13191_bib14","first-page":"21","article-title":"ATG-Fresenius or daclizumab induction therapy in immunologically high risk kidney recipients: A prospective randomized pilot trial","volume":"13","author":"Kim","year":"2008","journal-title":"Ann Transplant"},{"key":"10.1111\/ajt.13191_bib15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/01.tp.0000442505.10490.20","article-title":"Outcome and cost analysis of induction immunosuppression with IL2Mab or ATG in DCD kidney transplants","volume":"97","author":"Popat","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13191_bib16","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMc0805714","article-title":"Long-term results of rabbit antithymocyte globulin and basiliximab induction","volume":"359","author":"Brennan","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13191_bib17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/01.tp.0000219817.18049.36","article-title":"Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients","volume":"81","author":"Opelz","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13191_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/TP.0b013e318257ad41","article-title":"Alemtuzumab induction therapy in kidney transplantation: A systematic review and meta-analysis","volume":"93","author":"Morgan","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/ajt.13191_bib19","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"INTAC Study Group. Alemtuzumab induction in renal transplantation","volume":"364","author":"Hanaway","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.13191_bib20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/MNH.0b013e328365b3b9","article-title":"Transplanting the highly sensitized patient: Trials and tribulations","volume":"22","author":"Iyer","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/ajt.13191_bib21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1012376","article-title":"Desensitization in HLA-incompatible kidney recipients and survival","volume":"365","author":"Montgomery","year":"2011","journal-title":"N Engl J Med"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.13191","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522003008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522003008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:43:03Z","timestamp":1761626583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522003008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1600613522003008"],"URL":"https:\/\/doi.org\/10.1111\/ajt.13191","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.13191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}